Natalie Crawford, PhD
Associate Professor in Behavioral, Social and Health Education Sciences
Rollins School of Public Health, Emory University
Co-Director, Prevention and Implementation Sciences Core, Emory CFAR
Dr. Natalie Crawford is an Associate Professor in Behavioral, Social and Health Education Sciences in the Rollins School of Public Health at Emory University. She is also the Co-Director of the Prevention and Implementation Sciences Core in the Center for AIDS Research at Emory. Trained in social epidemiology, she received her PhD and MPH in Epidemiology from Columbia University’s Mailman School of Public Health. Dr. Crawford completed her post-doctoral training at the University of Michigan as a Robert Wood Johnson Health and Society Scholar. She is also a graduate of Spelman College where she trained in Women Studies and Biochemistry. Dr. Crawford's broad research interests are examining the social processes that create and perpetuate racial and ethnic disparities in HIV. Her research examines the impact of structural interventions in non-traditional health care settings on reducing racial inequities in HIV among marginalized populations.
About INSIGHTS (Innovative Non-traditional healthcare Settings in HIV research lecture Series): The purpose of this lecture series is to provide the community of HIV researchers with space and time to hear about innovative research conducted outside of traditional healthcare settings. This research includes any HIV-related interventions that can be applied to HIV research, including those that are conducted outside of the clinic (e.g., pharmacy, patients’ homes, CBO, mobile vans unrelated to the clinic, outdoors), can increase access to medications without involving clinics, or can enhance PrEP or ART adherence and persistence without clinic input.
This lecture series is funded by the UCSF CFAR Boost award.
Learning Objectives: Participants will be able to 1) define a structural intervention, 2) describe the epidemiology of the HIV epidemic in the US by race and geography and 3) describe the ways pharmacies can decrease HIV transmission.